Nafamostat added to the list of possible treatments today.

#SunPharma receives approval from DCGI to initiate clinical trial with Nafamostat in Covid-19 patients. 

#Covid19 #CoronaVirusUpdate #coronavirus #IndiaFightsCOVID19 #IndiaFightsCorona #investing #investment #stocks https://t.co/ZEPmXGauCr https://t.co/RGQMf1Pc2E